Chiral chromium hydroxide nano material and preparation method thereof

By adding chiral ligands and reducing agents during the precipitation of chromium hydroxide, chiral chromium hydroxide nanomaterials are prepared, which solves the cross-reaction problem of chromium-based materials in drug applications, and improves their dispersion and biological phase in water. Capacity achieves more efficient bioavailability.

CN118993149AInactive Publication Date: 2024-11-22JIANGNAN UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202410576561.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-05-10
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing chromium-based materials have cross-reaction problems between trivalent and hexavalent states in drug applications, which affects their clinical application and biocompatibility, making it difficult to effectively change their dispersion and bioavailability in solvents.

Method used

Chiral chromium hydroxide nanomaterials are prepared by adding chiral ligands and reducing agents during the precipitation of chromium hydroxide by solvent dispersion, changing their particle size and surface functional groups, and improving dispersion and biocompatibility in water.

Benefits of technology

The prepared chiral chromium hydroxide nanomaterial has good dispersion in water and has near-infrared chiral signals, which improves its bioavailability and biocompatibility, and is suitable for more efficient and stable drug development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118993149A_ABST
    Figure CN118993149A_ABST
Patent Text Reader

Abstract

The invention relates to a chiral chromium hydroxide nano material and a preparation method thereof, and belongs to the technical field of chiral materials. The preparation method disclosed by the invention comprises the following step: enabling a chromium source solution, a chiral ligand solution and a reducing agent solution to react in a solvent to obtain the chiral chromium hydroxide nano material. The chiral chromium hydroxide nano material has excellent optical activity, has CD activity in a near-infrared region, and can be used for identification and detection of polarized light by using near-infrared CD. According to the preparation method disclosed by the invention, the chiral ligand participates in the forming process of the chromium hydroxide nano-material, so that surface functional groups of the chromium hydroxide nano-material can be changed, and the dispersity and biocompatibility of the chromium hydroxide nano-material in water are improved. And due to the excellent high biocompatibility and high safety, the hydrogel can be more suitable for the living body environment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of chiral materials, and in particular relates to a chiral chromium hydroxide nanomaterial and a preparation method thereof. Background Art

[0002] Chirality means that if an object cannot overlap with its mirror image after a certain rotation or movement, it proves that the object has chirality. As one of the basic properties of nature, from sugars, amino acids, DNA and proteins in the microscopic field, to right-handed spiral snails, vines and rotating windmills in daily life, to the vast universe, all of these have chiral structures, which is the embodiment of chirality from micro to macro. Therefore, the asymmetric spiral morphology has become the most common chiral morphology and the most common morphology in nature. In the long river of human history, Tao follows nature has always been the law followed by mankind. These rich and strange chiral configurations have also attracted great attention from scientific researchers. Chirality plays an important role in physics, astronomy, medicine, biology, chemistry and pharmacy.

[0003] Chromium-based materials are widely used in the biomedical field due to their excellent biocompatibility and biodegradability. Chromium is an essential trace element for the human body. Although the required amount is very small, with only 6-7 mg in the normal human body, it is very important to the human body. It is mainly distributed in bones, skin, adrenal glands, brain and muscles. It is an important element for normal growth and development and blood sugar regulation. It also has the function of protecting cardiovascular and controlling weight. However, current studies have found that chromium has two valence states, trivalent chromium and hexavalent chromium. Trivalent chromium is beneficial to the human body, while hexavalent chromium is harmful to the human body. When used as a drug, there is a serious cross-reaction problem, which has a certain impact on human health and affects its clinical application. The use of chiral ligands and reducing agents to induce the preparation of chiral chromium hydroxide nanomaterials can improve the dispersibility of the prepared nanoparticles in the solvent by changing its valence state or internal surface functional groups, thereby increasing the range of influence of the material on cells, improving its bioavailability and biocompatibility, and providing new ideas and methods for the further development of more efficient and stable chromium-based drugs in the future. Summary of the invention

[0004] In order to solve the above technical problems, the present invention provides a chiral chromium hydroxide nanomaterial and a preparation method thereof. The chiral chromium hydroxide nanomaterial is obtained by adding a chiral ligand into the formation process of chromium hydroxide precipitation by means of a solvent dispersion method. The product has good dispersibility in water, a particle size of 3nm-5nm, and a near-infrared chiral signal.

[0005] The first object of the present invention is to provide a method for preparing a chiral chromium hydroxide nanomaterial, comprising the following steps: a chromium source solution, a chiral ligand solution and a reducing agent solution react in a solvent to obtain the chiral chromium hydroxide nanomaterial.

[0006] In one embodiment of the present invention, the chromium source is selected from one or more of chromium phosphate, chromium acetate, chromium chloride, chromium sulfate, chromium oxide and chromium nitrate.

[0007] In one embodiment of the present invention, the chiral ligand is selected from one or more of cysteine, histidine, mannose, arginine and methionine.

[0008] In one embodiment of the present invention, the configurations of cysteine, histidine, mannose, arginine and methionine are selected from L-type and / or D-type.

[0009] In one embodiment of the present invention, the reducing agent is selected from one or more of sodium hydroxide, methylamine, hydrazine hydrate and ammonia water.

[0010] In one embodiment of the present invention, the solvent is selected from one or more of water, ethanol, methanol, ethylene glycol, isopropanol and dimethyl sulfoxide.

[0011] In one embodiment of the present invention, the volume ratio of the chromium source solution, the chiral ligand solution and the reducing agent solution is 1-4:1-6:0.2-4.

[0012] In one embodiment of the present invention, the concentration ratio of the chromium source solution, the chiral ligand solution and the reducing agent solution is 0.2-0.4:0.2-0.4:0.2-2.

[0013] In one embodiment of the present invention, the reaction temperature is 20°C-50°C, the reaction time is 12h-24h, and the stirring speed is 600rpm-1000rpm.

[0014] In one embodiment of the present invention, after the reaction is completed, the steps of centrifugation, washing and drying are further included.

[0015] The second object of the present invention is to provide a chiral chromium hydroxide nanomaterial prepared by the preparation method.

[0016] In one embodiment of the present invention, the particle size of the chiral chromium hydroxide nanomaterial is 3nm-5nm, the characteristic peak of the circular dichroism spectrum signal is 450nm-500nm or 500nm-550nm, and the chiral configuration g value is 0.01-0.014.

[0017] The technical solution of the present invention has the following advantages over the prior art:

[0018] (1) The chiral chromium hydroxide nanomaterial of the present invention has excellent optical activity and CD activity in the near-infrared region. By utilizing near-infrared CD, it can be used for the identification and detection of polarized light.

[0019] (2) The preparation method of the present invention can change the surface functional groups of chromium hydroxide nanomaterials by involving chiral ligands in the formation process, thereby improving their dispersibility and biocompatibility in water. Taking advantage of their excellent biocompatibility and safety, they can better adapt to the environment of the organism. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] In order to make the content of the present invention more clearly understood, the present invention is further described in detail below according to specific embodiments of the present invention in conjunction with the accompanying drawings, wherein:

[0021] Figure 1 The CD image and UV image of the chiral chromium hydroxide nanomaterial of Test Example 1 of the present invention; wherein the left image is the CD image, and the right image is the UV image;

[0022] Figure 2 TEM images of the chiral chromium hydroxide nanomaterial of Test Example 2 of the present invention; wherein the left image is a TEM image with a scale of 50 nm, and the right image is a TEM image with a scale of 20 nm;

[0023] Figure 3 The X-ray powder diffraction pattern (XRD) of the chiral chromium hydroxide nanomaterial of Test Example 3 of the present invention;

[0024] Figure 4 This is an XPS graph of the chiral chromium hydroxide nanomaterial of Test Example 4 of the present invention; wherein the left graph is an energy spectrum graph of all elements of chromium hydroxide, and the right graph is an energy spectrum graph of the chromium element;

[0025] Figure 5 This is the EDX image of the chiral chromium hydroxide nanomaterial of Test Example 5 of the present invention; wherein, the left image is the TEM-HAADF image of chromium hydroxide, and the right image is the chromium element distribution map. DETAILED DESCRIPTION

[0026] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.

[0027] The detection method involved in the present invention is as follows:

[0028] (1) CD spectrum test: J-1700CD spectrophotometer equipped with a PMT detector in the range of 300-1000 nm was used for CD research. Typical scanning parameters: temperature: 25°C; scanning speed, 200 nm / min; data spacing: 0.5 nm; bandwidth: 5 nm (near infrared bandwidth: 10 nm); digital integration time: 2 s.

[0029] (2) UV test: A J-1700CD spectrophotometer equipped with a 300-1000 nm range PMT detector was used for UV studies. Typical scanning parameters: temperature: 25°C; scanning speed, 200 nm / min; data spacing: 0.5 nm; bandwidth: 5 nm (near infrared bandwidth: 10 nm); digital integration time: 2 s.

[0030] (3) TEM test: First, take 1 mL of the stock solution, spin at 8000 rpm for 5 min, remove the supernatant, and disperse in 1 mL of high-purity water. Repeat twice. The sample is dropped onto a copper grid and allowed to dry naturally at room temperature. Transmission electron microscopy (TEM) images are taken using a Talos F200X G2 at an accelerating voltage of 200 kV.

[0031] (4) XRD test: The dried solid samples were collected, ground with a mortar, and then subjected to XRD test. X-ray diffraction (XRD) was performed on a Bruker D8 using Cu Kα irradiation with a scan rate of 10 min. -1 , the range is 5°-90°, the target voltage is 40kV, and the current is 40mA.

[0032] (5) XPS test: Collect dried samples and perform the test using an X-ray photoelectron spectrometer.

[0033] (6) EDX test: The sample preparation method is the same as that of TEM, and the test instrument is Talos F200X G2 X-ray photoelectron spectrometer.

[0034] Example 1

[0035] The chiral chromium hydroxide nanomaterial and preparation method thereof of the present embodiment specifically include the following steps:

[0036] A chromium nitrate aqueous solution with a concentration of 0.2M is prepared; an L-cysteine ​​aqueous solution with a concentration of 0.2M is prepared; and a methylamine aqueous solution with a concentration of 1M is prepared; the solutions are added to 10mL of ethanol in sequence, wherein the amount of the chromium source aqueous solution added is 1mL, the amount of the L-cysteine ​​aqueous solution added is 1mL, and the amount of the methylamine aqueous solution added is 0.5mL, and the mixture is stirred uniformly at 800rpm for 16h at 20°C. After the reaction is completed, the mixture is centrifuged, washed, and dried to finally obtain a chiral chromium hydroxide nanomaterial.

[0037] Example 2

[0038] The chiral chromium hydroxide nanomaterial and preparation method thereof of the present embodiment specifically include the following steps:

[0039] Aqueous solutions of chromium chloride and chromium oxide are prepared with a concentration of 0.2M; an aqueous solution of D-methionine is prepared with a concentration of 0.2M; and an aqueous solution of hydrazine hydrate is prepared with a concentration of 0.5M; they are added into 12mL of methanol in sequence, wherein the amount of the chromium source aqueous solution added is 2mL, the amount of the D-methionine aqueous solution added is 2mL, and the amount of the hydrazine hydrate aqueous solution added is 1mL, and the mixture is stirred uniformly at 30°C and 1000rpm for 12h. After the reaction is completed, the mixture is centrifuged, washed, and dried to finally obtain a chiral chromium hydroxide nanomaterial.

[0040] Example 3

[0041] The chiral chromium hydroxide nanomaterial and preparation method thereof of the present embodiment specifically include the following steps:

[0042] A chromium sulfate aqueous solution with a concentration of 0.3M, a D-mannose aqueous solution with a concentration of 0.3M, and a sodium hydroxide aqueous solution with a concentration of 0.2M are prepared; they are added to 14mL of dimethyl sulfoxide in sequence, wherein the amount of the chromium source aqueous solution added is 2mL, the amount of the D-mannose aqueous solution added is 3mL, and the amount of the sodium hydroxide aqueous solution added is 1.5mL, and the mixture is uniformly stirred at 50°C and 600rpm for 12h. After the reaction is completed, the mixture is centrifuged, washed, and dried to finally obtain a chiral chromium hydroxide nanomaterial.

[0043] Example 4

[0044] The chiral chromium hydroxide nanomaterial and preparation method thereof of the present embodiment specifically include the following steps:

[0045] A chromium phosphate aqueous solution with a concentration of 0.4M is prepared; a D-arginine aqueous solution with a concentration of 0.4M is prepared; and an ammonia aqueous solution with a concentration of 0.2M is prepared; the solutions are added to 15mL of isopropanol in sequence, wherein the amount of the chromium source aqueous solution added is 4mL, the amount of the D-arginine aqueous solution added is 6mL, and the amount of the ammonia aqueous solution added is 4mL; the mixture is stirred uniformly at 50°C and 800rpm for 12h; after the reaction is completed, the mixture is centrifuged, washed, and dried to finally obtain a chiral chromium hydroxide nanomaterial.

[0046] Example 5

[0047] The chiral chromium hydroxide nanomaterial and preparation method thereof of the present embodiment specifically include the following steps:

[0048] A chromium chloride aqueous solution with a concentration of 0.2M is prepared; an L-histidine aqueous solution with a concentration of 0.4M is prepared; and a sodium hydroxide aqueous solution with a concentration of 2M is prepared; these are added to 15mL of ethylene glycol in sequence, wherein the amount of the chromium source aqueous solution added is 1mL, the amount of the L-histidine aqueous solution added is 1mL, and the amount of the sodium hydroxide aqueous solution added is 0.2mL; the mixture is uniformly stirred at 800rpm for 24h at 30°C; after the reaction is completed, the mixture is centrifuged, washed, and dried to finally obtain a chiral chromium hydroxide nanomaterial.

[0049] Test Example 1

[0050] The chiral chromium hydroxide nanomaterial of Example 1 was subjected to CD spectrum test and UV test, and the results were as follows: Figure 1 As shown. Figure 1 It can be seen that the characteristic peak of the circular dichroism spectral signal of the chiral chromium hydroxide nanomaterial is 450nm-500nm or 500nm-550nm.

[0051] Test Example 2

[0052] The chiral chromium hydroxide nanomaterial of Example 2 was subjected to TEM test, and the results were as follows: Figure 2 As shown. Figure 2 It can be seen that the particle size of the chiral chromium hydroxide nanomaterial is about 3nm-5nm.

[0053] Test Example 3

[0054] The chiral chromium hydroxide nanomaterial of Example 3 was subjected to XRD test, and the results were as follows: Figure 3 shown.

[0055] Test Example 4

[0056] The chiral chromium hydroxide nanomaterial of Example 4 was subjected to XPS testing, and the results were as follows: Figure 4 As shown. Figure 4 It can be seen that the main valence state of chromium element in chiral chromium hydroxide nanomaterials is trivalence, which is beneficial to the human body.

[0057] Test Example 5

[0058] The chiral chromium hydroxide nanomaterial of Example 5 was subjected to EDX testing, and the results were as follows: Figure 5 As shown. Figure 5 It can be seen that the chromium element is evenly distributed in the chiral chromium hydroxide nanomaterial.

[0059] In summary, the chiral chromium hydroxide nanomaterial of the present invention has high safety, good dispersibility in water, CD activity in the near-infrared region, and good biocompatibility.

[0060] Obviously, the above embodiments are merely examples for clear explanation and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the protection scope of the invention.

Claims

1. A method for preparing a chiral chromium hydroxide nanomaterial, characterized in that: The following steps are involved: The chromium source solution, the chiral ligand solution and the reducing agent solution react in a solvent to obtain the chiral chromium hydroxide nanomaterial.

2. The method for preparing a chiral chromium hydroxide nano material according to claim 1, wherein: The chromium source is selected from one or more of chromium phosphate, chromium acetate, chromium chloride, chromium sulfate, chromium oxide and chromium nitrate.

3. The method for preparing a chiral chromium hydroxide nano material according to claim 1, wherein: The chiral ligand is selected from one or more of cysteine, histidine, mannose, arginine and methionine.

4. The method for preparing a chiral chromium hydroxide nano material according to claim 3, wherein: The configurations of cysteine, histidine, mannose, arginine and methionine are selected from L-type and / or D-type.

5. The method for preparing a chiral chromium hydroxide nano material according to claim 1, characterized in that: The reducing agent is selected from one or more of sodium hydroxide, methylamine, hydrazine hydrate and ammonia water.

6. The method for preparing a chiral chromium hydroxide nano material according to claim 1, characterized in that: The solvent is selected from one or more of water, ethanol, methanol, ethylene glycol, isopropanol and dimethyl sulfoxide.

7. The method for preparing a chiral chromium hydroxide nanomaterial according to claim 1, characterized in that: The volume ratio of the chromium source solution, the chiral ligand solution and the reducing agent solution is 1-4:1-6:0.2-4.

8. The method for preparing a chiral chromium hydroxide nanomaterial according to claim 1, characterized in that: The concentration ratio of the chromium source solution, the chiral ligand solution and the reducing agent solution is 0.2-0.4:0.2-0.4:0.2-2.

9. A chiral chromium hydroxide nanomaterial prepared by the preparation method according to any one of claims 1 to 8.

10. The chiral chromium hydroxide nanomaterial according to claim 9, characterized in that: The particle size of the chiral chromium hydroxide nanomaterial is 3nm-5nm, the characteristic peak of the circular dichroism spectrum signal is 450nm-500nm or 500nm-550nm, and the chiral configuration g value is 0.01-0.014.

Citation Information

Patent Citations

  • Preparation method and application of nickel hydroxide inorganic nanoparticles with chiral optical activity in near-infrared region

    CN113247972A